Skip to search formSkip to main contentSkip to account menu

S 5682

Known as: S-5682, S5682 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
1 The effects of a purified micronized flavonoid fraction (S5682) on mean internal diameter and blood flow of arterioles and… 
1997
1997
The aim was to study the effect of oral administration of three different doses of S-5682 and alpha-tocopherol on an oxidant… 
1997
1997
Daflon 500 mg (S-5682) is a purified, micronized flavonoid fraction containing 90% diosmin and 10% hesperidin that is currently… 
1995
1995
The effects of a clinically used purified micronized flavonoid fraction (S5682) containing 90% diosmin and 10% hesperidin on… 
Highly Cited
1993
Highly Cited
1993
The efficacy and safety of a new veno-active flavonoid fraction (S 5682) consisting of micronized diosmin (90%) and hesperidin… 
Highly Cited
1989
Highly Cited
1989
S 5682 is a purified flavonoid fraction containing 90% diosmin (flavone derivative) and 10% hesperidin (flavanone derivative). In… 
1988
1988
Activation of the complement system during the early phase of inflammation is partly responsible for increased vascular… 
1988
1988
S 5682 is constituted by a flavonoid mixture of 90% diosmin and 10% hesperidin. Its action has been studied in vivo on… 
Highly Cited
1987